Emtricitabine, F/TAF Found To Be Safe And Effective In Reducing HIV Infection Risk For Cisgender Men, Transgender Women, Study Finds

Infectious Disease Advisor (8/4, Gupta) reports, “Emtricitabine and tenofovir alafenamide (F/TAF) was found to be safe and effective in reducing the risk of HIV infection in high-risk cisgender men and transgender women who have sex with men, according to...